Skip to main content
. 2020 Nov 2;24(23):13876–13898. doi: 10.1111/jcmm.15979

Table 4.

Changes in body mass

Group n Before the experiment At the end of the 12th week At the end of the 20th week
Blank 12 20.6 ± 1.3 23.7 ± 1.5▼ 25.9 ± 1.8▼▲
Model 12 20.1 ± 0.9 27.1 ± 1.7▼* 29.4 ± 0.7▼▲*
Simvastatin + aspirin 12 20.0 ± 1.2 26.6 ± 1.6▼*◇ 27.4 ± 1.4▼△*◆
DSYM low dose 13/12 20.6 ± 1.5 27.2 ± 1.4▼*◇ 27.9 ± 1.3▼△*◆
DSYM high dose 13/12 20.3 ± 1.5 27.3 ± 1.2▼*◇ 27.6 ± 1.5▼△*◆

(1) Within the group: compared with ‘before the experiment’ ▼ P < .01; compared with ‘at the end of the 12th week’, △ P > .05, ▲ P < .01. (2) Between groups: compared with the blank group * P < .01; compared with the model group, ◇P > .05, ◆ < .01.